Buy or sell Estimize stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Estimize Stock

Financial estimates using aggregation from independent analysts

About Estimize Stock

Estimize is an open financial estimates platform which facilitates the aggregation of fundamental estimates from independent, buy-side, and sell-side analysts, along with those of private investors and students. Estimize has over 5149 analysts’ contributors, resulting in coverage on over 900 stocks each quarter. The firm was founded in 2011 by former quantitative hedge fund analyst Leigh Drogen, with the belief that the financial ecosystem was ready for an estimates platform built with an open and transparent philosophy. The Estimize consensus estimate is regularly referenced in notable financial media sources such as Forbes, Barron’s, The Wall Street Journal, CNN Money, The Street, Investor’s Business Daily and Business Week, amongst others. Estimize data is now available on major financial research platforms such as Bloomberg.

Funding History

May 2011$200K
September 2012$1.2M
March 2014$1.2M
April 2015$6.0M
July 2015$3.6M

Management

Co-Founder and CEO

Leigh Drogen

Chief Technology Officer

Brian Smith

Head of Product and Analytics

Josh Dulberger

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Estimize or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo